{"id":3454,"date":"2017-11-13T17:02:32","date_gmt":"2017-11-13T22:02:32","guid":{"rendered":"http:\/\/www.ipoboutique.com\/blog\/?p=3454"},"modified":"2017-11-13T17:03:22","modified_gmt":"2017-11-13T22:03:22","slug":"secondaries-announced-11-13-17","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/secondaries-announced-11-13-17\/","title":{"rendered":"Secondaries Announced 11.13.17"},"content":{"rendered":"

IPO BOUTIQUE CLIENTS\u00a0and\u00a0IPO BOUTIQUE SECONDARY ALERTS CLIENTS\u00a0received ALL this information to their inbox on a\u00a0REAL TIME\u00a0basis.<\/strong><\/h4>\n

If having\u00a0real-time alerts for secondary offerings<\/strong><\/a>\u00a0would be an advantage to you,\u00a0inquire about a subscription today!<\/a><\/p>\n

Our Buy, Neutral or Avoid ratings of the Secondaries below are intended as a recommendation for those who buy Secondaries on a regular basis. For example, this is not to be interpreted as a Buy recommendation in the traditional sense of adding to your stock portfolio; this is a short term (usually one day or opening trade) time period.<\/p>\n

Company: ReWalk Robotics, Ltd.<\/strong>
\nSymbol: RWLK
\nPrice: Last Trade $1.50
\nTrade Date: 11\/17
\nShares: 4 million ($6 million raise)
\nUnderwriter(s) : National Securities
\nDescription: They are an innovative medical device company that is designing, developing and commercializing exoskeletons that allow individuals with mobility impairments or other medical conditions the ability to stand and walk once again.
\nRating = Subscription Needed<\/a><\/strong><\/p>\n

Company: Sage Therapeutics
\nSymbol: SAGE
\nPrice: Last Trade $94.65
\nTrade Date: 11\/15
\nShares: 3.2 million ($300m cash raise)
\nUnderwriter(s) : J.P. Morgan, Goldman Sachs, Morgan Stanley
\nDescription: Sage Therapeutics is a clinical-stage biopharmaceutical company committed to developing novel medicines to transform the lives of patients with life-altering central nervous system (CNS) disorders.
\nRating = Subscription Needed<\/a><\/strong><\/p>\n

Company: ProQR Therapeutics<\/strong>
\nSymbol: PRQR
\nPrice: Last Trade $3.48
\nTrade Date: 11\/14
\nShares: 5.75 million ($20m cash raise)
\nRe-Offer Range:Subscription Needed<\/a><\/strong>
\nUnderwriter(s) : H.C. Wainwright
\nDescription: ProQR Therapeutics is dedicated to changing lives through the creation of transformative RNA medicines for the treatment of severe genetic rare diseases such as cystic fibrosis, Leber\u2019s congenital amaurosis 10 and dystrophic epidermolysis bullosa.
\nRating = Subscription Needed<\/a><\/strong><\/p>\n

Company: Gardner Denver Holdings<\/strong>
\nSymbol: GDI
\nPrice: Last Trade $29.41
\nTrade Date: 11\/16
\nShares: 22 million
\nUnderwriter(s) : Goldman Sachs, Citigroup, KKR
\nDescription: They are a leading global provider of mission-critical flow control and compression equipment and associated aftermarket parts, consumables and services, which they sell across multiple attractive end-markets within the industrial, energy and medical industries.
\nRating = Subscription Needed<\/a><\/strong><\/p>\n

Company: Appian, Inc.
\nSymbol: APPN
\nPrice: Last Trade $23.25
\nTrade Date: 11\/16
\nShares: 3.8 million
\nUnderwriter(s) : Morgan Stanley, Goldman Sachs, Barclays
\nCo-Manager(s): William Blair, Canaccord Genuity, KeyBanc Capital, Cowen, SunTrust Robinson, BTIG
\nDescription: Appian provides a leading low-code software development platform as a service that enables organizations to rapidly develop powerful and unique applications. The applications created on our platform help companies drive digital transformation and competitive differentiation.
\nRating = Subscription Needed<\/a><\/strong><\/p>\n

Company: Third Point Reinsurance, Ltd.
\nSymbol: TPRE
\nPrice: Last Trade $16.89
\nTrade Date: 11\/14
\nShares: 15 million
\nRe-Offer Range: Subscription Needed<\/a><\/strong>
\nUnderwriter(s) : J.P. Morgan
\nDescription: The Company is a public company listed on the New York Stock Exchange which, through its wholly-owned subsidiaries Third Point Reinsurance Company Ltd. and Third Point Reinsurance (USA) Ltd., writes property and casualty reinsurance business.
\nRating = Subscription Needed<\/a><\/strong><\/p>\n

Company: Hyatt Hotels Corporation – Block
\nSymbol: H
\nPrice: Last Trade $69.74
\nTrade Date: 11\/14
\nShares: 0.63 million
\nRe-Offer Range: Subscription Needed<\/a><\/strong>
\nUnderwriter(s) : Morgan Stanley
\nDescription: Hyatt Hotels Corporation, a hospitality company, develops, owns, operates, manages, franchises, licenses, or provides services to full and select service hotels, resorts, and residential and other properties.
\nRating = Subscription Needed<\/a><\/strong><\/p>\n

Company: Floor & Decor Holdings
\nSymbol: FND
\nPrice: Last Trade $39.07
\nTrade Date: 11\/16
\nShares: 9 million
\nUnderwriter(s) : BofA Merrill Lynch, Barclays, Credit Suisse, UBS Investment Bank, Goldman Sachs & Co., Jefferies, Piper Jaffray, Wells Fargo Securities
\nCo-Manager: BTIG
\nDescription: Floor & Decor is a multi-channel specialty retailer of hard surface flooring and related accessories, offering a broad in-stock assortment of tile, wood, laminate and natural stone flooring along with decorative and installation accessories at everyday low prices.
\nRating = Subscription Needed<\/a><\/strong><\/p>\n

Company: Rapid 7, Inc.-BLOCK<\/strong>
\nSymbol: RPD
\nPrice: Last Trade $19.36
\nTrade Date: 11\/14
\nShares: 0.9 million
\nRe-Offer Range: Subscription Needed<\/a><\/strong>
\nUnderwriter(s) : Morgan Stanley
\nDescription: Rapid7 is a leading provider of security data and analytics solutions that enable organizations to implement an active, analytics-driven approach to cyber security.
\nRating = Subscription Needed<\/a><\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"

IPO BOUTIQUE CLIENTS\u00a0and\u00a0IPO BOUTIQUE SECONDARY ALERTS CLIENTS\u00a0received ALL this information to their inbox on a\u00a0REAL TIME\u00a0basis. If having\u00a0real-time alerts for secondary offerings\u00a0would be an advantage to you,\u00a0inquire about a subscription today! Our Buy, Neutral or Avoid ratings of the Secondaries below are intended as a recommendation for those who buy Secondaries on a regular basis.[…]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[35],"tags":[1182,1073,1198,941,528,915,310,1415],"class_list":["post-3454","post","type-post","status-publish","format-standard","hentry","category-secondary-offerings","tag-appn","tag-fnd","tag-gdi","tag-h","tag-rpd","tag-rwlk","tag-sage","tag-tpre"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/3454","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=3454"}],"version-history":[{"count":2,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/3454\/revisions"}],"predecessor-version":[{"id":3456,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/3454\/revisions\/3456"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=3454"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=3454"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=3454"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}